Tom Storey
Position:
Vice President, Head of Business Development
Company: Angitia Biopharmaceuticals
Location: Thousand Oaks, CA, USA
Professional Summary:
Tom Storey is an accomplished business development executive and general manager with over 19 years of experience. His expertise spans business development and strategy in both large- and mid-cap companies.
Experience:
1. Head of Business Development at Angitia Biopharmaceuticals
- Vice President role.
- Leading business development activities at Angitia, a biotechnology research company.
- Active in strategic planning and execution, focusing on expanding market reach and driving company growth.
- Demonstrates significant leadership in oncology and solid tumors projects, indicating a robust pipeline in these therapeutic areas.
Education:
- UCLA Anderson School of Management: Notable academic background enhancing his strategic and managerial capabilities.
Company Overview:
Angitia Biopharmaceuticals:
- Industry: Biotechnology Research
- Company Size: 51-200 employees
- Headquarters: Thousand Oaks, California
- Mission: Focused on discovering, developing, and commercializing breakthrough therapeutics to meet large unmet medical needs, particularly in serious musculoskeletal diseases.
- Values: Integrity, Collaboration, and Innovation.
- Website: [Angitia Biopharmaceuticals](https://www.angitiabio.com)
Key Insights:
- Tom Storey has been actively involved in the business development sector, riding on nearly two decades of experience.
- He currently plays a pivotal role at Angitia Biopharmaceuticals, positioning the company to address unmet medical needs through breakthrough therapeutics.
- His leadership is reflective in strategic growth initiatives and fostering collaborations essential for the company's long-term objectives.
- The company’s emphasis on integrity, collaboration, and innovation aligns with Tom's role in steering the strategic direction and ensuring successful business outcomes.
Noteworthy Activities:
- Engaged in setting goals for oncology and solid tumor discussions for the year 2024.
- Actively participates in industry-relevant updates, demonstrated through his engagement with team expansions and acquisitions within the biopharmaceutical space.
This report synthesizes Tom Storey’s professional trajectory and his contributions to Angitia Biopharmaceuticals, providing valuable intelligence for strategic engagements.
